Cx58 is associated with the metastasis of non-small cell lung cancer via MEF2B/Cx58 axis

Connexins (Cxs), also known as gap junction proteins, are structurally related transmembrane proteins and have been implicated in carcinogenesis. Although some evidence suggests that these proteins are tumor suppressors due to their reduced expression in cancers, recent research indicates their comp...

Full description

Saved in:
Bibliographic Details
Main Authors: Tan Fen, Chen Juan, Sun Lunquan, Zhang Lu, Zhou Rui
Format: Article
Language:English
Published: China Science Publishing & Media Ltd. 2025-04-01
Series:Acta Biochimica et Biophysica Sinica
Subjects:
Online Access:https://www.sciengine.com/doi/10.3724/abbs.2025049
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849735886882734080
author Tan Fen
Chen Juan
Sun Lunquan
Zhang Lu
Zhou Rui
author_facet Tan Fen
Chen Juan
Sun Lunquan
Zhang Lu
Zhou Rui
author_sort Tan Fen
collection DOAJ
description Connexins (Cxs), also known as gap junction proteins, are structurally related transmembrane proteins and have been implicated in carcinogenesis. Although some evidence suggests that these proteins are tumor suppressors due to their reduced expression in cancers, recent research indicates their complicated roles in tumor progression during different stages, including metastasis. Here, we show that Cx58, which is upregulated in non-small cell lung cancer (NSCLC), is modulated by myocyte-enhancer binding factor 2B (MEF2B). Either Cx58 or MEF2B knockdown attenuates the migration and invasion of NSCLC cells by inducing cytoskeleton rearrangement. Additionally, the prometastatic role of Cx58 in NSCLC is demonstrated in vivo. In conclusion, our findings suggest that Cx58 is transcriptionally activated by MEF2B and is involved in the metastasis of NSCLC by regulating cytoskeleton organization. Targeting the MEF2B/Cx58 axis may be exploited as a modality for improving NSCLC therapy.
format Article
id doaj-art-63fbeeb144a34b8aa3c96350e9eae5ff
institution DOAJ
issn 1672-9145
language English
publishDate 2025-04-01
publisher China Science Publishing & Media Ltd.
record_format Article
series Acta Biochimica et Biophysica Sinica
spelling doaj-art-63fbeeb144a34b8aa3c96350e9eae5ff2025-08-20T03:07:25ZengChina Science Publishing & Media Ltd.Acta Biochimica et Biophysica Sinica1672-91452025-04-01571292130310.3724/abbs.202504920d259ccCx58 is associated with the metastasis of non-small cell lung cancer via MEF2B/Cx58 axisTan Fen0Chen Juan1Sun Lunquan2Zhang Lu3Zhou Rui4["Department of Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha 410011, China"]["Department of Pulmonary and Critical Care Medicine, Shenzhen People’s Hospital, Shenzhen 518020, China"]["Center for Molecular Medicine, Xiangya Hospital, Central South University, Changsha 410008, China"]["Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China","Shanghai Key Laboratory of Thoracic Tumor Biotherapy, , Shanghai 200030, China"]["of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha 410011, China"]Connexins (Cxs), also known as gap junction proteins, are structurally related transmembrane proteins and have been implicated in carcinogenesis. Although some evidence suggests that these proteins are tumor suppressors due to their reduced expression in cancers, recent research indicates their complicated roles in tumor progression during different stages, including metastasis. Here, we show that Cx58, which is upregulated in non-small cell lung cancer (NSCLC), is modulated by myocyte-enhancer binding factor 2B (MEF2B). Either Cx58 or MEF2B knockdown attenuates the migration and invasion of NSCLC cells by inducing cytoskeleton rearrangement. Additionally, the prometastatic role of Cx58 in NSCLC is demonstrated in vivo. In conclusion, our findings suggest that Cx58 is transcriptionally activated by MEF2B and is involved in the metastasis of NSCLC by regulating cytoskeleton organization. Targeting the MEF2B/Cx58 axis may be exploited as a modality for improving NSCLC therapy.https://www.sciengine.com/doi/10.3724/abbs.2025049connexin58NSCLCmetastasisMEF2B
spellingShingle Tan Fen
Chen Juan
Sun Lunquan
Zhang Lu
Zhou Rui
Cx58 is associated with the metastasis of non-small cell lung cancer via MEF2B/Cx58 axis
Acta Biochimica et Biophysica Sinica
connexin58
NSCLC
metastasis
MEF2B
title Cx58 is associated with the metastasis of non-small cell lung cancer via MEF2B/Cx58 axis
title_full Cx58 is associated with the metastasis of non-small cell lung cancer via MEF2B/Cx58 axis
title_fullStr Cx58 is associated with the metastasis of non-small cell lung cancer via MEF2B/Cx58 axis
title_full_unstemmed Cx58 is associated with the metastasis of non-small cell lung cancer via MEF2B/Cx58 axis
title_short Cx58 is associated with the metastasis of non-small cell lung cancer via MEF2B/Cx58 axis
title_sort cx58 is associated with the metastasis of non small cell lung cancer via mef2b cx58 axis
topic connexin58
NSCLC
metastasis
MEF2B
url https://www.sciengine.com/doi/10.3724/abbs.2025049
work_keys_str_mv AT tanfen cx58isassociatedwiththemetastasisofnonsmallcelllungcancerviamef2bcx58axis
AT chenjuan cx58isassociatedwiththemetastasisofnonsmallcelllungcancerviamef2bcx58axis
AT sunlunquan cx58isassociatedwiththemetastasisofnonsmallcelllungcancerviamef2bcx58axis
AT zhanglu cx58isassociatedwiththemetastasisofnonsmallcelllungcancerviamef2bcx58axis
AT zhourui cx58isassociatedwiththemetastasisofnonsmallcelllungcancerviamef2bcx58axis